Skip to content
OpenCapital
Get started

Opus Genetics IRD Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$3.1MBeat by $7.6KDiluted EPS-$0.12Beat by $0.02
Revenue estimate$3.1M
EPS estimate-$0.14

Next report

Aug 12, 2026 (in a month)
Revenue estimate$2.6M
EPS estimate-$0.15

Financials

Q3 2025

Income statement

See full
Revenue$3.1M-20.4%
Operating income-$8.3M-3.8%
Net income-$17.5M-132%
EPS (diluted)-$0.25+13.8%

Balance sheet

See full
Cash & equivalents$30.8M-15.9%
Total debt$1.1M—
Total equity$6.0M-82.6%
Total assets$36.1M-10.6%

Cash flow

See full
Operating cash flow-$6.2M-20.0%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$98.85M—
Enterprise value$69.1M—
P/S6.8×—

Profitability

See full
Operating margin-445.4%+162pp
Net margin-466.1%+361pp

Returns & leverage

See full
Return on equity-338.8%-442pp
Debt / equity0.2×—
Current ratio1.2×-5.4×

Versus estimates

Revenue

Q4 2025$3.9MBeat by $721.0KQ1 2026$2.2MMiss by $771.1K
Q3 2025$3.1MBeat by $7.6K
Q2 2025$2.9MMiss by $201.3KQ1 2025$4.4MBeat by $970.0KQ4 2024$4.3MBeat by $913.5K

Diluted EPS

Q4 2025-$0.19Miss by $0.03Q1 2026-$0.75Miss by $0.59
Q3 2025-$0.12Beat by $0.02
Q2 2025-$0.12Beat by $0.13Q1 2025-$0.32Beat by $0.02Q4 2024-$1.27Miss by $0.93

Ask the moment Opus Genetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Opus Genetics report Q3 2025 earnings?
Opus Genetics (IRD) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Opus Genetics's Q3 2025 revenue and EPS?
Opus Genetics reported revenue of $3.1M and diluted EPS of $-0.12 for Q3 2025.
Did Opus Genetics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $3.1M by $7.6K. EPS beat the consensus estimate of $-0.14 by $0.02.
How did Opus Genetics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 20.4% from $3.9M a year earlier and diluted EPS grew 58.6% from $-0.29.
Where can I find Opus Genetics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-041544) and the 10-Q periodic report (0001140361-25-041547) directly on SEC EDGAR. The filing index links above go to sec.gov.